LBA21KEYNOTE-119: Phase III study of pembrolizumab (pembro) versus single-agent chemotherapy (chemo) for metastatic triple negative breast cancer (mTNBC)
Cortés, J, Lipatov, O, Im, S-A, Gonçalves, A, Lee, K S, Schmid, P, Tamura, K, Testa, L, Witzel, I, Ohtani, S, Zambelli, S, Harbeck, N, André, F, Dent, R, Zhou, X, Karantza, V, Mejia, J A, Winer, E PVolume:
30
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz394.010
Date:
October, 2019
File:
PDF, 83 KB
english, 2019
File converter
More search results
More benefits 
